Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia after Initial Clearance of Bloodstream Infection

Table 3

Clinical outcomes.

Variable presented as #(%) or median (IQR)	Ceftriaxone (n = 20)	SOCT alone (n = 23)	value
Clinical cure	10 (50)	18 (78.3)	0.052
WBC normal in 7 days	12 (60)	20 (87)	0.043
Temp normal in 7 days	20 (100)	23 (100)	1.000
Culture clear in 7 days	16 (80)	18 (78.3)	1.000
Microbiological cure	16 (80)	21 (91.3)	0.393
Recurrence within 60 days	2 (10)	3 (13)	1.000
Hospital length of stay	16.5 [9–22.75]	12 [8–26]	0.669
MSSA length of stay	16 [8.25–22.75]	11 [8–19]	0.479
Discharge disposition
Death	1 (5)	1 (4.3)	1.000
Home	13 (65)	16 (69.6)	0.750
SNF/Rehab	6 (30)	6 (26.1)	0.775
Alive, not readmitted or retreated	16 (80)	17 (73.9)	0.728
Infection-related readmission	2 (10)	4 (17.4)	0.669
Not infection-related readmission	2 (10)	1 (4.3)	0.590

WBC = white blood cell; MSSA = methicillin-susceptible Staphylococcus aureus; SNF = skilled nursing facility; Rehab = rehabilitation facility.